ImmPACT Bio
CAR-T Cell Therapies for Treating Cancer
Active
Acquired
Startup
Rehovot
Founded 2017-04
ImmPACT Bio is a clinical-stage company dedicated to the discovery of transformative chimeric antigen receptor (CAR) T-cell therapies for cancer patients who have exhausted their treatment options. The company's logic-gate-based CAR T platforms address key biological challenges in treating cancer. ImmPACT Bio's technologies are specifically designed to prev…
SectorHealth Tech & Life Sciences
StageAcquired
Total raised$137.0M
Employees49
Founded2017-04
HQRehovot
Crunchbaseimmpact-bio-usa
Patents1
Confidence89
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals